Dennis E. Marshall - Sep 29, 2024 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Director
Signature
/s/ John R. Browning, attorney-in-fact
Stock symbol
BLGO
Transactions as of
Sep 29, 2024
Transactions value $
$0
Form type
4
Date filed
10/1/2024, 05:14 PM
Previous filing
Jul 1, 2024
Next filing
Dec 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLGO Option to Purchase Common Stock Award +93.7K +2.18% 4.39M Sep 29, 2024 Common Stock 93.7K $0.24 Direct F1, F2
transaction BLGO Option to Purchase Common Stock Award +81.5K +1.86% 4.47M Sep 30, 2024 Common Stock 81.5K $0.23 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Option was granted to Reporting Person to replace an option to purchase 47,872 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
F2 Total reflects the expiration of options to purchase 47,872 shares that recently expired.
F3 This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2024 Equity Incentive Plan.